Digital Health
M&A: ArisGlobal Acquires SPORIFY to Expand Regulatory Solutions
What You Should Know: ArisGlobal, a provider of life sciences software acquires SPORIFY, the trusted substances, products, organizations and referentials…
What You Should Know:
- ArisGlobal, a provider of life sciences software acquires SPORIFY, the trusted substances, products, organizations and referentials (SPOR) data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies. Financial details of the acquisition were not disclosed.
- With its second acquisition in the last 90 days, ArisGlobal is prioritizing the development of an open architecture that enables an interconnected life sciences ecosystem.
- The addition of SPORIFY will improve patient safety with interoperable systems and data standards, bring therapies to market faster, and allow stakeholders to react to supply chain disruptions quickly.
About SPORIFY
SPORIFY provides consistent and ISO IDMP-compliant SPOR data to feed regulatory activities across the product life cycle, enabling more informed, proactive regulatory decisions to benefit public health and safety. It is the trusted SPOR data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies and several European regulators.
Keep it Short
By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
Seattle startup Olamedi building platform to automate health clinic communications
A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…
